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T.A. Mehta,1* J. Greenman,1 C. Ettelaie,2 A. Venkatasubramaniam,1 I.C. Chetter1 and
P.T. McCollum1Introduction. There is growing evidence that heat shock proteins (HSPs), a family of stress-inducible proteins may be
involved in the pathogenesis of atherosclerotic vascular diseases. Here, we systematically review the evidence behind this
notion.
Methods. A detailed literature search and extensive bibliographic review of literature relating to HSPs and atherosclerotic
vascular disease.
Results. Atherosclerotic vascular disease is classified into four main areas of presentation: carotid, coronary, aortic and
peripheral vascular disease, for consideration in this review. In each of these vascular diseases, the evidence linking HSPs and
atherosclerosis is outlined in a systematic manner. Current evidence suggests that components of the immune system may be
involved in the pathogenesis of atherosclerosis, with HSPs acting as auto-antigens in the immune response. HSPs are
detected in atherosclerotic lesions and antibodies to HSPs are increased in patients with vascular disease; the rise often
correlating with the severity of atherosclerosis. The levels of anti-HSP antibodies have been shown to be independent
predictors of risk and have prognostic value.
Conclusion. There is a strong link between heat shock protein expression and the principal manifestations of atherosclerotic
vascular diseases. A better understanding of this involvement could lead to the development of new and improved treatment
strategies.Keywords: Heat shock proteins; Vascular disease; Review.Introduction
More than 40 years ago, Ritossa observed that
exposing larval salivary glands from Drosophila to
heat, induced specific genes in the giant chromosomes
of these cells.1 It is now known that these genes code
for a family of proteins called heat shock proteins.
Heat shock proteins (HSPs) are a group of highly
conserved proteins found in the cells of all organisms,
from the simplest of prokaryotes to the most complex
mammals including man.2 The term heat shock
protein, however, is a misnomer. A better title would
be ‘stress proteins’, because in addition to raised
temperature, HSP synthesis is increased in response to
many environmental stresses (stress-inducible) likeing author. Tapan Mehta, Vascular Laboratory, Hull
ry, Anlaby Road, Hull HU3 2JZ, UK.
: tapanmehta99@yahoo.com
0395+ 08 $35.00/0 q 2005 Elsevier Ltd. All rights reseroxidative stress, nutritional deficiency, ultraviolet
radiation, chemicals, viruses and ischaemia-reperfu-
sion injury. Although stress-inducible, low levels of
HSP expression occurs in normal physiological con-
ditions (constitutive expression) making up 5–10% of
the total protein content in healthy growth con-
ditions.3,4
HSPs function as molecular chaperones guiding
newly formed polypeptides through folding/unfold-
ing steps to achieve correct functional configuration.5
They are also involved in protein transport across
intracellular membranes and the repair of denatured
proteins (Fig. 1). HSPs are grouped into various
families according to their molecular weight: namely
the 110, 90, 70, 60, 40 kDa and low molecular weight
families. A selection of the more important members
of the HSP family are detailed in Table 1. HSPs have
been implicated in the pathogenesis of several disease
processes, however, their role in atherosclerosisEur J Vasc Endovasc Surg 29, 395–402 (2005)
doi:10.1016/j.ejvs.2005.01.005, available online at http://www.sciencedirect.com onved.
Fig. 1. Two functions of heat shock proteins. Top: as new
polypeptide chains (proteins) are being produced by ribo-
some within the cell, heat shock proteins assist in correct
folding of polypeptide chain into functional protein.
Presence of heat shock protein (purple) assures that the
new protein will assume its functional three-dimensional
configuration. Bottom: after stress event, heat shock proteins
also assist in refolding or degradation of damaged or
denatured proteins.3
T. A. Mehta et al.396particularly is widely studied. The aim of this review
is to highlight the link between HSPs and athero-
sclerotic vascular disease.Methods
Literature relevant to this review was identified by a
systematic search in the Medline (PubMed) database
from 1960 onwards. A random search of Medline
using HSP as a key word revealed more than 20,000
citations. HSP, vascular disease and human were used
to limit the search, which was further restricted toTable 1. Key members of the heat shock protein family in humans3,4
HSP member Location
Low molecular weight HSPs
Ubiquitin Cytoplasm/nucleus
HSP10 Mitochondria
HSP27 Cytoplasm/nucleus
Ab-crystallin Cytoplasm
HSP40
HSP40 Cytoplasm/nucleus
HSP47 Endoplasmic reticulum
HSP60
HSP60 Mitochondria
HSP70
HSP72 Cytoplasm/nucleus
HSP73 Cytoplasm/nucleus
HSP75 Mitochondria
HSP90
HSP90 Cytoplasm (migrates to nucleus)
HSP110
HSP110 Nucleolus/cytoplasm
HSP105 Cytoplasm
Eur J Vasc Endovasc Surg Vol 29, April 2005papers in the English language. Papers dealing with in
vivo studies involving the role of HSPs in the
pathogenesis of atherosclerotic vascular disease were
accepted rather than in vitro studies in tissue and cell
samples. The search was refined by careful review of
references cited in key papers on HSP. For a clearer
understanding of the complex role of HSPs in
atherosclerotic vascular disease, such diseases are
classified into four main areas namely—carotid,
coronary, aortic and peripheral vascular disease.
After an initial overview of the pathogenesis of
atherosclerosis with particular reference to HSPs, the
link between HSPs and atherosclerosis is explored in
more detail in the four areas of vascular disease.HSP and Atherosclerosis
In relation to atherosclerosis, HSPs from the HSP60
and HSP70 families are most widely investigated.
Studies have shown that HSP60 localizes selectively in
atherosclerotic lesions as opposed to non-atherosclero-
tic regions of the arterial wall.6 In advanced athero-
sclerotic lesions, HSP70 is over expressed in several
cell types, including monocytes, macrophages, den-
dritic cells and smooth muscle cells. In early athero-
sclerotic lesions, however, only dendritic cells, which
are key cells in the immune response, over express
HSP70.7 Interestingly, HSPs, which are normally
intracellular, have also been found in a soluble form
in serum along with specific anti HSP antibodies, and
some studies suggest a correlation between the levels
of these antibodies and the severity of atherosclero-
sis.8,9
HSP have been investigated in association withDescription
Facilitates targeting and removal of denatured proteins
Cofactor for HSP60
Involved in cytoskeletal stabilisation
Involved in intracellular actin dynamics
Regulates activity of HSP70, binds non-native protein
Processing of pro-collagen
Molecular chaperone
Highly stress inducible, protects against ischaemia
Constitutively expressed molecular chaperone
Induced by stress including hypoxia
Part of the steroid receptor complex
Thermal tolerance
Protein refolding
Heat Shock Proteins in Vascular Disease 397many established risk factors for the development of
atherosclerosis and also as independent markers of the
disease. In a large population based study, high levels
of soluble HSP60 correlated with LDL cholesterol.10
Levels of anti-HSP 70 antibodies were significantly
and independently elevated in 111 established hyper-
tensive men as compared with 75 normotensive
controls.11 The same group also showed that HSP 70
antibodies may have a protective effect in hyperten-
sive subjects by modifying the progression of athero-
sclerosis.12 In British civil servants, an association was
found between HSP60 and various psychosocial
measures like low socio-economic status, social iso-
lation and psychological distress.13 In addition to
traditional risk factors for atherosclerosis, prominent
immunoreactivity against HSP60 was associated with
atherosclerosis in male youngsters as measured by
intima-media thickness in carotid and femoral
arteries.14 HSPs also have prognostic significance in
predicting morbidity and mortality due to athero-
sclerosis. In a cohort of 79 men with documented
coronary artery disease, significantly higher levels of
anti-HSP 65 antibodies were found in those who went
on to have cardiovascular events than those who did
not.15
Another HSP widely studied is Hemeoxygenase-1,
classified as HSP 32. Hemeoxygenase-1 is the induci-
ble form of hemeoxygenase, an enzyme essential for
heme degradation. It is induced by a variety of
stressors and performs anti-atherogenic functions in
the arterial wall like scavenging reactive oxygen
species, reducing monocyte adhesion and chemo-
taxis.16 It is unclear whether HSP are protective or
destructive for the organism and the role of HSPs in
atherosclerosis is most probably multifaceted.
One of the important areas of current research is to
investigate the role of HSPs in the association between
infection and atherosclerosis. Based on their obser-
vations, Wick et al. have proposed an autoimmune
hypothesis of atherogenesis. HSP60 is expressed by
the endothelial cells of stressed arteries and because of
sequence homology between microbial and human
HSP60, the cost of immunity against micro organisms
may be responsible for endothelial cell damage and
early atherosclerosis.17 This notion is explored further
in relation to key areas of atherosclerotic vascular
disease.Carotid Disease
Initial work in atherosclerosis and HSPs focussed on
carotid disease, possibly because of the ease of
measuring atherosclerotic lesions in the carotid arteryby ultrasound scanning. In a landmark paper, Xu and
colleagues studied 867 randomly selected normal
inhabitants of South Tyrol and showed that serum
anti-HSP65 antibodies were significantly elevated in
elderly subjects with carotid atherosclerosis. Further, a
significant positive correlation was found between
anti-HSP65 antibodies and the thickness of the
atherosclerotic plaque in the carotid artery as
measured by ultrasonography.18 Anti-HSP65 antibody
titre elevation was sustained in persons with severe
and progressive carotid disease and was an indepen-
dent predictor of mortality at 5 years.19 Carotid
atherosclerosis is an important cause of ischaemic
stroke. In 180 stroke patients, anti-HSP65 and anti-
HSP70 antibodies were significantly elevated 48 h
after ischaemic stroke compared to controls, and
multiple regression analysis showed these antibodies
to be independent risk factors for stroke.20 Not
surprisingly although anti-HSP70 antibody level was
a risk factor for ischaemic stroke, HSP70 itself may be a
marker for neuroprotection in the early stages of
ischaemic stroke.21 Many mechanisms have been
suggested for HSP70 protection from cerebral ischae-
mia including defence against apoptotic and necrotic
cell death.22
Anti-HSP antibodies maybe produced in response
to infection and this possibly provides a link between
atherosclerosis and chronic infection. Infection with
Chlamydia pneumoniae seems a likely suspect. Anti-C.
pneumoniae antibodies are most closely associated with
carotid atherosclerosis as opposed to antibodies to
other infectious agents. This association is indepen-
dent of other risk factors, consistent over time and for
different stages of atherosclerosis. The antibody titre
correlates with intima-media thickness and with anti-
HSP65 antibodies. Anti-C. pneumoniae antibodies may
be produced by sub-clinical infection, but interestingly
evidence of chronic C. pneumoniae respiratory infection
was more effective in predicting atherosclerotic carotid
disease.23 In addition to humoral factors, cell-
mediated immunity to C. pneumoniae has also been
associated with the pathogenesis of atherosclerosis.
Established T-cell lines were propagated from acti-
vated T-lymphocytes isolated from tissue specimens of
patients undergoing carotid endarterectomy. Forty-
one percent of the propagated T-cell lines reacted with
C. pneumoniae peptides and majority of these were
from the HSP60 antigen.24 In another study, C.
pneumoniae was present in the endothelial cells,
activated macrophages and smooth muscle cells in
90% of the specimens harvested at carotid endarter-
ectomy. Chlamydial HSP60 was found in all specimens
positive for C. pneumoniae-specific antigen and mainly
co-localised with this antigen in the activatedEur J Vasc Endovasc Surg Vol 29, April 2005
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infected macrophages in the pathogenesis of carotid
atherosclerosis.25 In summary, microbial infection
causes immune reactions involving HSPs via humoral
and cell-mediated immune systems. Since, HSPs are
preserved with similar antigenic properties across
different species, antibodies and stimulated T cells
may then cross-react with host endothelial cells
expressing such molecules perhaps promoting
atherogenesis.Coronary Disease
Ischaemic heart disease is the most common cause of
death in the Western world and extensive studies on
HSPs and coronary atherosclerotic disease have been
performed. The relationship between HSPs and most
aspects of ischaemic heart disease has been studied
including presence and severity of coronary artery
atherosclerosis, coronary syndromes, myocardial
infarction (MI), ischaemia-reperfusion injury and
cardiac protection. In patients with coronary artery
disease (CAD), antibodies to both HSP65 and HSP60
have been shown to be significantly associated with
both presence and severity of the disease. Higher titres
were found with increasing number of diseased
vessels and also greater extent of disease, as measured
by coronary atherosclerosis scores.26,27 Hsp65 anti-
body, although elevated in patients with CAD,
significantly fell in patients following acute MI. It is
hypothesized, based on animal models of MI that
HSPs are released in the circulation from the infarcted
heart tissue and these bind to circulating anti-HSP
antibodies to form antigen–antibody complexes,
which are subsequently removed from the circulation
by the reticuloendothelial system.28 In addition,
following percutaneous transluminal coronary angio-
plasty, anti-HSP65 antibody titres dropped in patients
who remained disease-free, but remained elevated in
those who developed restenosis. A fall in HSP
antibody titre maybe associated with a favourable
outcome, and may serve as a useful prognostic marker
for coronary angioplasty.29 Levels of HSP60 and
HSP65 are associated with more severe forms of
CAD, but some other HSPs may have a protective
effect. High levels of human HSP70 were shown to be
associated with low CAD risk, suggesting a more
complex role for these proteins in coronary
atherosclerosis.30
In coronary atherosclerotic disease circumstantial
evidence links infection, immunity and the athero-
sclerotic process with HSPs, particularly infection
with C. pneumoniae. A strong association betweenEur J Vasc Endovasc Surg Vol 29, April 2005antibodies to the organism and coronary artery disease
has long been established31,32 and C. pneumoniae has
also been detected in atheromatous plaques,33,34 but
how C. pneumoniae might induce or promote athero-
sclerosis was not clear until recently. In surgical
specimens from human atherosclerotic arteries, Chla-
mydial HSP60 and human HSP60 were found to co-
localize within atherosclerotic plaque macrophages
and both were shown to potently stimulate the
production of tumour necrosis factor (TNF) and
MMP-9 by the macrophages.6 Chlamydial lipopolysac-
charide has been demonstrated to induce mono-
nuclear phagocyte foam cell formation and
Chlamydial HSP60 was shown to induce low-density
lipoprotein (LDL) oxidation.35 These steps are highly
relevant to atherogenesis and plaque complications.
Further evidence of this coronary atherosclerosis/
Chlamydial infection/HSPs association is suggested in
other clinical studies. High levels of anti-human
HSP60 antibodies and C. pneumoniae antibodies were
found to be independent risk factors for coronary
atherosclerosis, and their simultaneous presence sub-
stantially increased the risk of disease development.36,
37 Using multivariate analysis to account for other risk
factors high levels of anti-ChlamydialHSP60 antibodies
were again shown to be independently associated with
coronary artery disease and could identify the subset
of patients with Chlamydial infection and significant
CAD.38 A persistent elevation in the immune response
involving C. pneumoniae and HSP60, when present
together, better predicted coronary events than tran-
sient or individual elevations in these antibodies.39
This evidence has paved the way for research trials to
evaluate the role of immunomodulation, antibiotics
and vaccination against C. pneumoniae as interven-
tional measures in CAD.40,41 Although initial clinical
studies showed promising results, these new anti-
atherogenic measures have not yet had any long term
impact on atherosclerosis. Possibly, this is because of
wrong choice or short duration of antibiotics or the fact
that the disease aetiology is multi-factorial and not
simply dependent on one infectious agent.42,43 Long
term trials are required to investigate further this
interesting area of research.Aortic Disease
HSPs are implicated in atherosclerotic disease invol-
ving the abdominal aorta and its visceral branches.
Using immunohistochemical techniques in human
aortic specimens from autopsy, HSP70 was shown to
be present weakly throughout the media of apparently
normal looking specimens, and was highly
Heat Shock Proteins in Vascular Disease 399concentrated in the centre of thickened atheromatous
plaques around sites of necrosis and lipid accumu-
lation. The intensity of HSP70 staining correlated with
the thickness of the atherosclerotic plaque. Also the
increased HSP distribution was prominent in macro-
phages as opposed to smooth muscle cells or other
plaque cells.44 Another study investigating HSP70 in
the human aorta studied its distribution by immuno-
histochemistry and video image analysis software,
and quantified the level of HSP70 by Western Blotting.
This study showed a homogeneous staining pattern of
HSP70 in ‘normal-appearing’ regions, but a hetero-
geneous pattern in areas of atherosclerosis. The image
analysis indicated a significant positive correlation
between the severity of atherosclerosis and altered
pattern of HSP70 staining, but Western blotting
showed no difference in total content with plaque
progression. It is suggested that the heterogeneous
pattern of HSP distribution in atherosclerotic lesions
may be due to leakage of HSP70 from damaged cells
into the plaque.45 Stress-induced synthesis of HSPs
normally protects cells from death, but insufficient
accumulation of HSP70 in aortic smooth muscle cells,
near areas of necrosis, leads to death of such cells,
which further promotes plaque rupture and throm-
boembolic complications.46
Although most modern investigators question the
relationship between aortic aneurysmal disease and
atherosclerosis, immune responses have been studied
in abdominal aortic aneurysmal disease. Serum level
of anti-HSP70 antibodies was significantly higher in
patients with abdominal aortic aneurysms (AAA) than
controls indicating a role for humoral immune
response involving HSPs.47 Cell-mediated immunity
is also implicated as HSP60 expression was found in
intimal endothelial cells and mononuclear infiltrate (T-
lymphocytes and macrophages) of the aorta at sites of
branching and other large size arteries, but not in
smaller vessels. This distribution of immune cells
suggests that the stress of high velocity and haemo-
dynamic sheer forces may be responsible for the
recruitment of HSP-specific T cells.48 Infection may be
responsible for initiating the immune responses, and
once again C. pneumoniae has been implicated, as it
was detected in the vessel wall of AAA specimens
using different techniques including immunohisto-
chemistry, in situ hybridisation and polymerase chain
reaction. To satisfy the infection hypothesis, all
components of C. pneumoniae should be isolated in
the atherosclerotic plaque. Whilst Chlamydial lipopo-
lysaccharide and membrane protein antigens were
detected in abundance, Chlamydial DNA or HSPs were
not, and this was suggested to be due to the rapiddegradation of the HSPs and DNAwith persistence of
other antigens.49Peripheral Vascular Disease
Peripheral vascular disease (PVD) usually refers to
atherosclerotic chronic lower limb ischaemia. Patients
with PVD have three times higher mortality than age
and sex matched controls mainly because of co-
morbidity due to atherosclerotic disease in other
vascular beds.50 A number of studies have analysed
the role of HSPs in the pathogenesis of atherosclerotic
PVD and particularly the beneficial influence of
exercise. Levels of circulating HSP70 were signifi-
cantly elevated in 20 patients with PVD compared to
controls. Levels of anti-HSP70 antibodies were also
elevated but this did not reach statistical significance.
In the same study, anti-HSP60 antibody levels were
significantly elevated in patients with PVD and the
level demonstrated positive correlation with the
disease severity.51 Similarly, in another study, levels
of anti-HSP70 antibodies were found to be signifi-
cantly elevated in patients with PVD as compared
with controls and these levels were higher in patients
with critical ischaemia than in claudicants, again
suggesting that anti-HSP antibody levels bear some
correlation with disease severity.47 Diabetes mellitus is
one of the more important risk factors for the
development of PVD and anti-HSP70 antibody sub-
classes have been measured in 67 diabetic patients.
IgG and IgM class of anti-HSP70 antibodies were not
different as compared to controls, but IgA class anti-
HSP70 antibodies titres were significantly higher in
type I and II diabetics than in non-diabetic controls. It
has been suggested that IgA-containing immune
complexes may be implicated in the vascular compli-
cations of patients with diabetes mellitus and that
HSP70 may have a role as an auto antigen in the
pathogenesis of these diseases.52
Transluminal angioplasty is a common treatment
modality for patients with PVD, but the mechanical
stretch injury associated with balloon angioplasty can
lead to lipid accumulation, monocyte and platelet
adhesion, smooth muscle cell proliferation and new
plaque formation.53 Interestingly, the mechanical
stress of balloon angioplasty was shown to induce
HSP70 in the smooth muscle cells in of blood vessels
harvested from patients undergoing above-knee
amputations. On the basis of these results it has been
suggested that the induction of HSP70 expression may
be an important component of the response to injury
by blood vessels that is often described as the first step
in atherogenesis.54 HSP70 and HSP70 mRNA wasEur J Vasc Endovasc Surg Vol 29, April 2005
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different stages of PVD, using gel electrophoresis and
reverse transcriptase polymerase chain reaction tech-
niques, respectively. Both HSP70 and HSP70 mRNA
were significantly elevated in calf muscles from
patients with Fontaine stage II, III and IV PVD as
compared to controls. The highest levels were found in
stage III disease, whereas levels were lower in stage IV
disease, which is characterised by tissue loss. This was
hypothesized to be due to lack of exercise in patients
with stage IV disease. Exercise in patients with PVD
may cause an ischaemia-reperfusion type injury. Since
stage IV patients frequently have severely limited
mobility and are unable to exercise, there is an absence
of reperfusion injury and a reduction in HSP70
levels.55 Ischaemia reperfusion injury (IRI) has been
implicated in the pathogenesis of many diseases in the
heart, lung and intestines. In PVD ischaemia occurs
during walking to the point of claudication and
reperfusion occurs when the patient stops and rests.
This IRI has been suggested to cause inflammation and
atherosclerotic progression, perhaps accounting for
the higher mortality seen in these patients compared
to age and sex matched controls.56 Reperfusion of
ischaemic tissues initiates a complex series of reactions
that paradoxically injures tissues. Leucocyte-endo-
thelial interaction is a pivotal step in this IRI.
Thermotolerance, possibly mediated through the
induction of HSP72, attenuates ischaemia-reperfusion
induced leucocyte-endothelial interaction, the key
process in IRI.57
In healthy individuals, a bout of acute exercise
induces HSPs. Serum HSP70 levels were elevated
during and after a 60 min treadmill exercise in normal
humans.58 Although exercise increases the body
temperature, exercise-induced hyperthermia is not
the sole factor inducing HSP70 production; this is
likely to be a combination of mechanical, metabolic
and chemical stresses. It is inferred that this induction
of HSPs may play a role in the adaptation to exercise
and training.59 The role of HSPs in exercise in patients
with PVD merits further investigation.Conclusion
There is growing evidence that atherosclerosis may be
an inflammatory and possibly an immune disorder.
Due to a high degree of sequence homology between
human and microbial HSPs, anti-microbial HSP
antibodies produced in response to infection cross-
react with HSPs on endothelial cells stressed by
classical risk factors for atherogenesis. This ‘antigenic
mimicry’ causes endothelial damage and earlyEur J Vasc Endovasc Surg Vol 29, April 2005atherosclerotic lesions.60,61 In each of the four key
areas of vascular disease—carotid, coronary, aortic and
peripheral vascular disease—studies have shown a
substantial role of HSPs in the pathogenesis of these
diseases. In many cases they are independent risk
factors for the disease. Levels of HSPs or their specific
antibodies have a positive correlation with disease
severity and in some cases have prognostic value.
Although for the individual cell, HSPs are helpful for
cell survival as they perform important functions, it is
not clear that for the organism as a whole, HSPs are
beneficial or simply a double-edged sword playing a
role in the pathogenesis of fatal diseases. A more
comprehensive understanding of the role of HSPs in
atherosclerosis is likely to lead to new approaches for
the prevention and treatment for all forms of cardio-
vascular disease.References
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